VulnerabilityModified
CVE-2021-3029
EVOLUCARE ECSIMAGING (aka ECS Imaging) through 6.21.5 has an OS Command Injection vulnerability via shell metacharacters and an IFS manipulation.
CRITICAL 9.8EPSS 3.02%
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (3.02%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
EVOLUCARE ECSIMAGING (aka ECS Imaging) through 6.21.5 has an OS Command Injection vulnerability via shell metacharacters and an IFS manipulation. The parameter "file" on the webpage /showfile.php can be exploited to gain root access. NOTE: This vulnerability only affects products that are no longer supported by the maintainer
- CVSS 3.1
- 9.8 CRITICALCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 3.02% probability · 87th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-78
- Affected
- evolucare/ecs imaging
- Source
- cve@mitre.org
References
- https://shoxxdj.fr/ecsimaging-os-injection-cve-2021-3029/Third Party Advisory
- https://www.evolucare.comProduct
- https://shoxxdj.fr/ecsimaging-os-injection-cve-2021-3029/Third Party Advisory
- https://www.evolucare.comProduct
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.